• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

RNA N6-甲基腺嘌呤去甲基酶 FTO 抑制糖皮质激素诱导的骨髓间充质干细胞成骨分化和功能。

RNA N6-methyladenosine demethylase FTO inhibits glucocorticoid-induced osteoblast differentiation and function in bone marrow mesenchymal stem cells.

机构信息

Department of Paediatrics, Affiliated Maternity and Child Health Care Hospital of Nantong University, Nantong, China.

Department of Orthopedic Surgery, Affiliated Taian City Central Hospital of Qingdao University, Taian, Shandong, China.

出版信息

J Cell Biochem. 2023 Nov;124(11):1835-1847. doi: 10.1002/jcb.30492. Epub 2023 Oct 26.

DOI:10.1002/jcb.30492
PMID:37882437
Abstract

Excess glucocorticoids (GCs) have been reported as key factors that impair osteoblast (OB) differentiation and function. However, the role of RNA N6-methyladenosine (m A) in this process has not yet been elucidated. In this study, we report that both the mRNA and protein expression of fat mass and obesity-associated gene (FTO), a key m A demethylase, were dose-dependently downregulated during OB differentiation by dexamethasone (DEX) in bone marrow mesenchymal stem cells (BMSCs), and FTO was gradually increased during OB differentiation. Meanwhile, FTO knockdown suppressed OB differentiation and mineralization, whereas overexpression of wide-type FTO, but not mutant FTO (mutated m A demethylase active site), reversed DEX-induced osteogenesis impairment. Interfering with FTO inhibited proliferation and the expression of Ki67 and Pcna in BMSCs during OB differentiation, whereas forced expression of wide-type FTO improved DEX-induced inhibition of BMSCs proliferation. Moreover, FTO knockdown reduced the mRNA stability of the OB marker genes Alpl and Col1a1, and FTO-modulated OB differentiation via YTHDF1 and YTHDF2. In conclusion, our results suggest that FTO inhibits the GCs-induced OB differentiation and function of BMSCs.

摘要

过量的糖皮质激素(GCs)被认为是损害成骨细胞(OB)分化和功能的关键因素。然而,RNA N6-甲基腺苷(m A)在这个过程中的作用尚未阐明。在本研究中,我们报告说,在骨髓间充质干细胞(BMSCs)中,地塞米松(DEX)通过剂量依赖性地下调脂肪量和肥胖相关基因(FTO)的 mRNA 和蛋白表达,FTO 是一种关键的 m A 去甲基化酶,并且在 OB 分化过程中逐渐增加。同时,FTO 敲低抑制 OB 分化和矿化,而过表达野生型 FTO(突变 m A 去甲基化酶活性位点)则逆转了 DEX 诱导的成骨作用受损。在 OB 分化过程中,干扰 FTO 抑制了 BMSCs 的增殖和 Ki67 和 Pcna 的表达,而过表达野生型 FTO 则改善了 DEX 诱导的 BMSCs 增殖抑制。此外,FTO 敲低降低了 OB 标记基因 Alpl 和 Col1a1 的 mRNA 稳定性,并且 FTO 通过 YTHDF1 和 YTHDF2 调节 OB 分化。总之,我们的研究结果表明,FTO 抑制了 GCs 诱导的 BMSCs 中 OB 的分化和功能。

相似文献

1
RNA N6-methyladenosine demethylase FTO inhibits glucocorticoid-induced osteoblast differentiation and function in bone marrow mesenchymal stem cells.RNA N6-甲基腺嘌呤去甲基酶 FTO 抑制糖皮质激素诱导的骨髓间充质干细胞成骨分化和功能。
J Cell Biochem. 2023 Nov;124(11):1835-1847. doi: 10.1002/jcb.30492. Epub 2023 Oct 26.
2
The mA demethylase FTO promotes the osteogenesis of mesenchymal stem cells by downregulating PPARG.mA 去甲基化酶 FTO 通过下调 PPARG 促进间充质干细胞的成骨分化。
Acta Pharmacol Sin. 2022 May;43(5):1311-1323. doi: 10.1038/s41401-021-00756-8. Epub 2021 Aug 30.
3
Glucocorticoids suppressed osteoblast differentiation by decreasing Sema3A expression via the PIK3/Akt pathway.糖皮质激素通过 PIK3/Akt 通路降低 Sema3A 表达抑制成骨细胞分化。
Exp Cell Res. 2021 Jun 1;403(1):112595. doi: 10.1016/j.yexcr.2021.112595. Epub 2021 Apr 7.
4
Advanced glycation end products impair bone marrow mesenchymal stem cells osteogenesis in periodontitis with diabetes via FTO-mediated N-methyladenosine modification of sclerostin.晚期糖基化终产物通过 FTO 介导的骨硬化蛋白 N6-甲基腺苷修饰物损害糖尿病牙周炎骨髓间充质干细胞成骨作用。
J Transl Med. 2023 Nov 4;21(1):781. doi: 10.1186/s12967-023-04630-5.
5
RNA N6-methyladenosine demethylase FTO promotes osteoporosis through demethylating Runx2 mRNA and inhibiting osteogenic differentiation.RNA N6-甲基腺嘌呤去甲基酶 FTO 通过去甲基化 Runx2 mRNA 并抑制成骨分化促进骨质疏松症。
Aging (Albany NY). 2021 Sep 8;13(17):21134-21141. doi: 10.18632/aging.203377.
6
Demethylase FTO promotes mechanical stress induced osteogenic differentiation of BMSCs with up-regulation of HIF-1α.去甲基酶 FTO 通过上调 HIF-1α 促进机械应力诱导的 BMSCs 成骨分化。
Mol Biol Rep. 2022 Apr;49(4):2777-2784. doi: 10.1007/s11033-021-07089-z. Epub 2022 Jan 10.
7
microRNA-199a counteracts glucocorticoid inhibition of bone marrow mesenchymal stem cell osteogenic differentiation through regulation of Klotho expression in vitro.microRNA-199a 通过调控 Klotho 表达体外拮抗糖皮质激素抑制骨髓间充质干细胞成骨分化。
Cell Biol Int. 2020 Dec;44(12):2532-2540. doi: 10.1002/cbin.11460. Epub 2020 Sep 10.
8
The GDF11-FTO-PPARγ axis controls the shift of osteoporotic MSC fate to adipocyte and inhibits bone formation during osteoporosis.GDF11-FTO-PPARγ 轴控制骨质疏松症 MSC 命运向脂肪细胞的转移,并在骨质疏松症期间抑制骨形成。
Biochim Biophys Acta Mol Basis Dis. 2018 Dec;1864(12):3644-3654. doi: 10.1016/j.bbadis.2018.09.015. Epub 2018 Sep 14.
9
Dexamethasone induces osteogenesis via regulation of hedgehog signalling molecules in rat mesenchymal stem cells.地塞米松通过调节大鼠间充质干细胞中的 hedgehog 信号分子诱导成骨。
Int Orthop. 2013 Jul;37(7):1399-404. doi: 10.1007/s00264-013-1902-9. Epub 2013 May 5.
10
Foxf1 knockdown promotes BMSC osteogenesis in part by activating the Wnt/β-catenin signalling pathway and prevents ovariectomy-induced bone loss.Foxf1 敲低通过激活 Wnt/β-连环蛋白信号通路部分促进 BMSC 成骨,并预防去卵巢导致的骨丢失。
EBioMedicine. 2020 Feb;52:102626. doi: 10.1016/j.ebiom.2020.102626. Epub 2020 Jan 22.

引用本文的文献

1
FTO inhibited miR-487a-3p biosynthesis via N6-methyladenosine-dependent pathway to promote WNT5A-mediated osteogenic differentiation of adipose-derived stem cells.FTO通过N6-甲基腺苷依赖途径抑制miR-487a-3p的生物合成,以促进WNT5A介导的脂肪来源干细胞的成骨分化。
Hum Cell. 2025 Aug 27;38(5):152. doi: 10.1007/s13577-025-01273-0.
2
Biological interpretation of DNA/RNA modification by ALKBH proteins and their role in human cancer.ALKBH蛋白对DNA/RNA修饰的生物学解读及其在人类癌症中的作用。
Eur J Med Res. 2025 Jun 6;30(1):458. doi: 10.1186/s40001-025-02735-9.
3
Regulation of Skeletogenic Pathways by m6A RNA Modification: A Comprehensive Review.
m6A RNA修饰对成骨途径的调控:综述
Calcif Tissue Int. 2025 Apr 3;116(1):58. doi: 10.1007/s00223-025-01367-9.